Spyre Therapeutics (SYRE) Stock Chart & Stock Price History $25.26 +0.84 (+3.44%) (As of 12/17/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Spyre Therapeutics Stock Price Performance 5 Day Performance+4.73%1 Month Performance-11.89%3 Month Performance-12.78%6 Month Performance-2.06%Year-To-Date Performance+17.38%1 Year Performance+59.77% Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address DeFi Coin on Verge of Breakout! (Ad)The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years. Claim your FREE book now before it's too late! SYRE Stock Chart for Wednesday, December, 18, 2024 SYRE Chart by TradingView Spyre Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization12/17/2024$24.42$25.26+3.44%$25.36$23.14738,212 shs$1.30 billion12/16/2024$24.12$24.42+1.24%$25.01$23.44441,062 shs$1.26 billion12/13/2024$23.92$24.12+0.84%$24.45$23.50422,875 shs$1.24 billion12/12/2024$26.44$23.92-9.53%$26.79$23.90736,456 shs$1.23 billion12/11/2024$26.49$26.44-0.19%$27.00$25.80415,299 shs$1.36 billion12/10/2024$26.81$26.49-1.19%$27.24$26.15356,573 shs$1.36 billion Get the Latest News and Ratings for SYRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 12/09/2024$27.08$26.81-1.00%$27.64$26.76327,450 shs$1.38 billion12/06/2024$25.55$27.08+5.99%$27.19$25.77442,370 shs$1.39 billion12/05/2024$27.99$25.55-8.72%$27.92$25.13638,087 shs$1.31 billion12/04/2024$27.27$27.99+2.64%$28.18$26.87483,419 shs$1.44 billion12/03/2024$27.65$27.27-1.37%$29.06$26.93554,699 shs$1.40 billion12/02/2024$28.43$27.65-2.74%$28.67$27.32588,601 shs$1.42 billion11/29/2024$27.75$28.43+2.45%$28.55$27.78211,487 shs$1.46 billion11/28/2024$27.75$27.75$28.23$27.23504,592 shs$1.43 billion11/27/2024$27.83$27.75-0.29%$28.23$27.23504,592 shs$1.43 billion11/26/2024$27.81$27.83+0.07%$28.46$27.36626,616 shs$1.43 billion11/25/2024$27.70$27.81+0.40%$28.36$27.18869,421 shs$1.43 billion11/22/2024$27.00$27.70+2.59%$28.01$26.73781,502 shs$1.42 billion11/21/2024$27.50$27.00-1.82%$29.09$26.76820,948 shs$1.39 billion11/20/2024$26.90$27.50+2.23%$28.48$26.811.24 million shs$1.41 billion11/19/2024$28.67$26.90-6.17%$27.80$25.743.12 million shs$1.38 billion11/18/2024$29.20$28.67-1.82%$30.34$28.41348,336 shs$1.47 billion Related Companies BBIO Stock Chart CRNX Stock Chart KRYS Stock Chart TGTX Stock Chart ADMA Stock Chart ACLX Stock Chart RARE Stock Chart APLS Stock Chart BHVN Stock Chart RNA Stock Chart Receive SYRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Spyre Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SYRE) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredMissed Nvidia? Buy Elon Musk’s “Silent Partner”In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my f...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Spyre Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Spyre Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SYRE Stock Alerts